Vanberra Signal

Pregnolia

Curated by Signal

Provider of device for predicting chances of preterm births

Overview

Provider of device for predicting chances of preterm births. Its flagship product has a small probe that is used intra-vaginally to measure cervical stiffness. Cervical stiffness has been shown to be a useful parameter for the diagnosis of pre-term birth. The device is currently being validated clinically.

Key facts

Founded
2015

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Provider of soft implantable electrodes for neurological disorders

    Life Sciences TechnologyGeneva, Switzerland
  • Smart fertility tracking thermometer

    Life Sciences TechnologyZurich, Switzerland
  • Developer of remote controlled implant for treatment of obesity

    Life Sciences TechnologyLausanne, Switzerland

About Pregnolia

What does Pregnolia do?

Provider of device for predicting chances of preterm births.

Where is Pregnolia headquartered?

Pregnolia is headquartered in Zurich, Switzerland.

When was Pregnolia founded?

Pregnolia was founded in 2015.

Which sector is Pregnolia in?

Pregnolia operates in Life Sciences Technology.

Who are Pregnolia's competitors?

Companies similar to Pregnolia include Neurosoft Bioelectronics, Daysy, and Endoart.